Researchers at Valence Labs, powered by Recursion, have introduced OpenQDC (Open Quantum Data Commons), an extensive, publicly accessible quantum mechanical …
Swiss pharmaceutical giant Roche has announced its acquisition of Poseida Therapeutics, a San Diego-based biotech company specializing in next-generation cell …
Japanese researchers have identified a novel genetic cause for hepatocerebral mitochondrial DNA depletion syndrome (MTDPS), linking it to variants in …
Today, we’re diving into the results of Advarra’s 2024 Site-Sponsor-CRO Collaboration Survey, which highlights three major barriers hindering collaboration in …
Trogenix Ltd has launched its Odysseus platform, leveraging Synthetic Super-Enhancer (SSE) technology to advance precision viral immunotherapy for aggressive cancers.
Novartis has struck a licensing agreement with Boston-based biotech Ratio Therapeutics, securing global rights to a promising cancer candidate targeting …
Medable Inc. has introduced generative AI capabilities to its Medable Studio platform to streamline and accelerate digital and decentralized clinical …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.
